Drug Search Results

Tiropramide

Alternative Names: tiropramide
Latest Update: 2023-08-01
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: Calcium Reducer

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Indications: None

Known Adverse Events: None

Company: Daewoong
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Tiropramide

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 4: Irritable Bowel Syndrome

Trial	Phase	Trial Status	Disease	Primary Completion Date	Probability of Success
DW-TRP001	P4	Unknown status	Irritable Bowel Syndrome	2013-02-01

Recent News Events

Date	Type	Title
08/01/2023	PubMed	Chromatographic separation of tiropramide hydrochloride and its degradation products along with their structural characterization using liquid chromatography quadrupole time-of-flight tandem mass spectrometry and nuclear magnetic resonance.
04/18/2020	PubMed	Population Pharmacokinetic Analysis of Tiropramide in Healthy Korean Subjects.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions